The technology may become an alternative to conventional hemodialysis for people with end-stage kidney disease.
Present-day treatment generally requires three sessions a week on a stationary machine that restricts patients' ability to walk around while it is attached and running.
In contrast, a wearable device would allow patients to be mobile and untethered. It could also provide additional treatment benefits from longer sessions or more frequent days of dialysis.
Those leading the trial included the inventor of the device, Wearable Artificial Kidney prototype, Victor Gura of Cedar-Sinai Medical Center in Los Angeles-read more